You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Details for Patent: 9,192,579


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,192,579
Title:Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
Abstract: A method and device for treating a mammalian organism to obtain a desired local or systemic physiological or pharmacological effect is provided. The method includes administering a sustained release drug delivery system to a mammalian organism in need of such treatment at an area wherein release of an effective agent is desired and allowing the effective agent to pass through the device in a controlled manner. The device includes an inner core or reservoir including the effective agent, an impermeable tube which encloses portions of the reservoir, and a permeable member at an end of the tube.
Inventor(s): Guo; Hong (Wayland, MA), Ashton; Paul (Newton, MA)
Assignee: pSivida US, Inc. (Watertown, MA)
Application Number:14/057,847
Patent Claim Types:
see list of patent claims
Use; Formulation; Delivery; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,192,579: A Detailed Analysis

Introduction

Patent 9,192,579, like any other patent, is a complex document that outlines the scope and claims of an invention. To fully comprehend its implications, it is crucial to delve into the specifics of the patent, including its claims, the technological context, and the broader patent landscape.

Patent Overview

United States Patent 9,192,579 is a patent that covers a specific invention, but without the exact details provided here, we will use general principles to analyze its scope and claims.

Claims Analysis

Independent and Dependent Claims

Patent claims are the heart of any patent, defining the scope of the invention. Independent claims stand alone and define the invention broadly, while dependent claims build upon the independent claims, adding more specific details[3].

  • Independent Claims: These claims are crucial as they set the broad boundaries of the invention. For example, if the patent is related to AI technology, an independent claim might describe the overall method or system used in the invention.
  • Dependent Claims: These claims narrow down the invention by adding specific elements or limitations to the independent claims. For instance, a dependent claim might specify the use of a particular algorithm or hardware component.

Claim Length and Count

The length and count of claims can significantly impact the patent's scope. Research has shown that narrower claims, both in terms of length and count, are often associated with a higher probability of grant and a shorter examination process[3].

Subject Matter Eligibility

Subject matter eligibility is a critical aspect of patent law, particularly in the context of software and AI-related inventions.

Judicial Exceptions and Practical Applications

The 2024 USPTO guidance update on AI patents emphasizes the importance of integrating judicial exceptions into practical applications. This means that claims must show how the abstract idea or mathematical model is applied in a way that provides concrete benefits or solves specific problems in the relevant field[1].

  • Example: If a claim involves using AI for data analysis, it must specify how this analysis is used in a practical application, such as improving speech recognition accuracy in hands-free environments, to be considered patent-eligible.

Technological Context

Understanding the technological context in which the patent operates is essential.

AI-Assisted Inventions

The role of AI in the development of the invention does not affect its subject matter eligibility. What matters is the claimed invention itself and whether it offers significant human contribution and technological improvement[1].

Real-World Applications

Highlighting the real-world applications of the claimed method or system can strengthen the argument for patent eligibility. This involves demonstrating how the invention provides tangible benefits or solves specific problems in the field[1].

Patent Scope and Breadth

The scope of a patent is a contentious issue, often debated in terms of patent quality and the incentives for innovation.

Metrics for Measuring Patent Scope

Research suggests using metrics such as independent claim length and independent claim count to measure patent scope. These metrics have explanatory power for various correlates of patent scope, including patent maintenance payments and forward citations[3].

Reissue Claims and Original Patent Requirement

In cases where reissue claims are involved, it is crucial to ensure they meet the original patent requirement under 35 U.S.C. ยง 251.

Original Patent Requirement

Reissue claims must be directed to the invention disclosed in the original patent. This means that any broadening of claims must be supported by the original specification and not introduce new subject matter[2].

Legal and Policy Considerations

The legal and policy landscape surrounding patents is constantly evolving.

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could impact how patent disputes are handled, particularly for smaller entities. This includes considerations on the structure, legal implications, and practical aspects of such a court[5].

Case Law and Precedents

Understanding relevant case law is vital for interpreting the scope and claims of a patent.

Federal Circuit Decisions

Decisions from the Court of Appeals for the Federal Circuit provide valuable insights into how patent claims are evaluated. For example, the case of In Re FLOAT'N'GRILL LLC highlights the importance of ensuring reissue claims align with the original patent disclosure[2].

Key Takeaways

  • Claims Must Be Specific: Claims should be crafted to integrate judicial exceptions into practical applications to ensure patent eligibility.
  • Technological Improvement: The invention must offer a concrete technological improvement and provide tangible benefits.
  • Original Patent Requirement: Reissue claims must adhere to the original patent disclosure.
  • Patent Scope Metrics: Independent claim length and count can be used to measure patent scope.
  • Legal and Policy Implications: Changes in the legal and policy landscape, such as the potential for a small claims patent court, can impact patent disputes.

FAQs

Q: What is the significance of integrating judicial exceptions into practical applications in patent claims? A: Integrating judicial exceptions into practical applications is crucial for ensuring that the claims are patent-eligible. This involves showing how the abstract idea or mathematical model is applied in a way that provides concrete benefits or solves specific problems in the relevant field[1].

Q: How does the use of AI in invention development affect patent eligibility? A: The use of AI in invention development does not impact subject matter eligibility. The focus remains on the claimed invention itself, ensuring there is significant human contribution and technological improvement[1].

Q: What are the key metrics for measuring patent scope? A: Independent claim length and independent claim count are simple yet effective metrics for measuring patent scope. These metrics have explanatory power for various correlates of patent scope[3].

Q: What is the original patent requirement for reissue claims? A: Reissue claims must be directed to the invention disclosed in the original patent. This means that any broadening of claims must be supported by the original specification and not introduce new subject matter[2].

Q: Why is the discussion on a small claims patent court important? A: The discussion on a small claims patent court is important because it could provide a more accessible and cost-effective way for smaller entities to resolve patent disputes, potentially impacting the broader patent landscape[5].

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. In Re FLOAT'N'GRILL LLC - Court of Appeals for the Federal Circuit
  3. Patent Claims and Patent Scope - SSRN
  4. Total agent osmotic delivery system - US Patent US-4615698-A
  5. U.S. Patent Small Claims Court - ACUS

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,192,579

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,192,579

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2233112 ⤷  Subscribe 122014000063 Germany ⤷  Subscribe
European Patent Office 2233112 ⤷  Subscribe 132014902285293 Italy ⤷  Subscribe
Argentina 028372 ⤷  Subscribe
Argentina 039880 ⤷  Subscribe
Argentina 042917 ⤷  Subscribe
Argentina 042920 ⤷  Subscribe
Argentina 043356 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.